Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 3826 AL 3840

Early onset Alzheimer's disease - a case study

Łabuz-Roszak B, Torbus-Paluszczak M, Becelewski J, Becelewski M, Dobrakowski P, Pierzchała K.

Psychiatr Pol. 2021 Apr 30;55(2):323-330. doi: 10.12740/PP/OnlineFirst/114122. Epub 2021 Apr 30.

Subdural Hematoma as a Serious Complication of Huntington's Disease: An Observational Study

Davis M, Wheelock V, Talman L, Latimer C, Vicars B, Lin A, Jayadev S, Bird T.

J Huntingtons Dis. 2021;10(3):385-390. doi: 10.3233/JHD-210478.

Pet Therapy as a Nonpharmacological Treatment Option for Neurological Disorders: A Review of the Literature

Boldig CM, Butala N.

Cureus. 2021 Jul 4;13(7):e16167. doi: 10.7759/cureus.16167. eCollection 2021 Jul.

PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases

Cunha A, Gaubert A, Latxague L, Dehay B.

Pharmaceutics. 2021 Jul 8;13(7):1042. doi: 10.3390/pharmaceutics13071042.

Approach to Posture and Gait in Huntington's Disease

Talman LS, Hiller AL.

Front Bioeng Biotechnol. 2021 Jul 27;9:668699. doi: 10.3389/fbioe.2021.668699. eCollection 2021.

Mood and emotional disorders associated with parkinsonism, Huntington disease, and other movement disorders

Bono AD, Twaite JT, Krch D, McCabe DL, Scorpio KA, Stafford RJ, Borod JC.

Handb Clin Neurol. 2021;183:175-196. doi: 10.1016/B978-0-12-822290-4.00015-3.

Disorders of facial emotional expression and comprehension

Heilman KM.

Handb Clin Neurol. 2021;183:99-108. doi: 10.1016/B978-0-12-822290-4.00006-2.

Significant Association Between Huntingtin Gene Mutation and Prevalence of Hopelessness, Depression and Anxiety Symptoms

Butėnaitė A, Strumila R, Lengvenytė A, Pakutkaitė IK, Morkūnienė A, Matulevičienė A, Dlugauskas E, Utkus A.

Acta Med Litu. 2021;28(1):77-85. doi: 10.15388/Amed.2020.28.1.4. Epub 2021 Jan 21.

[Metabolic pathways controlled by E3 ligases: an opportunity for therapeutic targeting]

Taillandier D.

Biol Aujourdhui. 2021;215(1-2):45-57. doi: 10.1051/jbio/2021006. Epub 2021 Aug 16.

FOXO and related transcription factors binding elements in the regulation of neurodegenerative disorders

Oli V, Gupta R, Kumar P.

J Chem Neuroanat. 2021 Oct;116:102012. doi: 10.1016/j.jchemneu.2021.102012. Epub 2021 Aug 13.

A Curious Case of Excessive Winking

Medarametla S, Boraiah N, Raju S.

Mov Disord Clin Pract. 2021 May 29;8(6):947-949. doi: 10.1002/mdc3.13254. eCollection 2021 Aug.

Sars-Cov-2 in a Patient with Acute Chorea: Innocent Bystander or Unexpected Actor?

Cotta Ramusino M, Perini G, Corrao G, Farina L, Berzero G, Ceroni M, Costa A.

Mov Disord Clin Pract. 2021 Jul 9;8(6):950-953. doi: 10.1002/mdc3.13274. eCollection 2021 Aug.

In vivo Direct Conversion of Astrocytes to Neurons Maybe a Potential Alternative Strategy for Neurodegenerative Diseases

Wang Y, Zhang X, Chen F, Song N, Xie J.

Front Aging Neurosci. 2021 Aug 2;13:689276. doi: 10.3389/fnagi.2021.689276. eCollection 2021.

The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington's disease

Tung CW, Huang PY, Chan SC, Cheng PH, Yang SH.

J Biomed Sci. 2021 Aug 19;28(1):59. doi: 10.1186/s12929-021-00755-1.

Novel Substituted Heterocyclic and Heteroaryl Compounds for Treating Huntington's Disease

Sabnis RW.

ACS Med Chem Lett. 2021 Jul 20;12(8):1204-1205. doi: 10.1021/acsmedchemlett.1c00356. eCollection 2021 Aug 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias